Аспирин и риск кровотечений при вторичной профилактике

Обсуждение медицинских новостей

Модератор: Pyankov Vasily

Ответить
Pyankov Vasily
Сообщения: 5562
Зарегистрирован: Пн ноя 24, 2008 12:59 am
Откуда: Киров

Аспирин и риск кровотечений при вторичной профилактике

Сообщение Pyankov Vasily »

Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study


In patients receiving aspirin-based antiplatelet treatment without routine PPI use, the long-term risk of major bleeding is higher and more sustained in older patients in practice than in the younger patients in previous trials, with a substantial risk of disabling or fatal upper gastrointestinal bleeding. Given that half of the major bleeds in patients aged 75 years or older were upper gastrointestinal, the estimated NNT for routine PPI use to prevent such bleeds is low, and co-prescription should be encouraged.

http://www.thelancet.com/pdfs/journals/ ... 0770-5.pdf
Пьянков Василий Алексеевич
Ответить